| Identification | |
| Name: | Thieno[3,2-c]pyridine,5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-, hydrochloride (1:1) |
| Synonyms: | Ticlopidine HCL |
| CAS: | 53885-35-1 |
| EINECS: | 258-837-4 |
| Molecular Formula: | C14H14ClNS.HCl |
| Molecular Weight: | 300.2466 |
| InChI: | InChI=1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H |
| Molecular Structure: |  |
| Properties | |
| Water Solubility: | Soluble in ethanol; almost soluble in water |
| Solubility: | Soluble in ethanol; almost soluble in water |
| Appearance: | White powder |
| Specification: | White Solid usageEng:An antithrombotic. a platelet aggregation inhibitor Safety Statements:36-37/39-26 36:Wear suitable protective clothing 37/39:Wear suitable protective clothing, gloves and eye/face protection 26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice |
| Biological Activity: | Selective P2Y 12 receptor antagonist. Inhibits ADP-induced platelet aggregation and displays antithrombotic activity following oral administration in vivo . |
| Storage Temperature: | Desiccate at RT |
| Usage: | An antithrombotic. a platelet aggregation inhibitor |
| Safety Data | |
| Hazard Symbols |
Xn:Harmful
|
 |
|
